Literature DB >> 15495786

Circulating ICAM-1, VCAM-1, E-selectin, P-selectin, and TNFRII in patients with coronary artery disease.

M Hajilooi1, A Sanati, A Ahmadieh, A Ghofraniha, Ahmad Massoud.   

Abstract

OBJECTIVE: To evaluate the relationship between the serum concentration of tumor necrosis factor receptor 2 (TNFRII) and some adhesion molecules [including intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), P-Selectin, and E-Selectin] and coronary artery stenosis. DESIGN AND
SETTING: Observational (cross-sectional) study in a University Heart Hospital in Tehran, Iran. PATIENTS: 75 patients with angiographically proven coronary artery disease were compared with 81 individuals who had undergone coronary angiography with no significant evidence of stenosis (control subjects).
METHODS: Soluble adhesion molecules and TNFRII were determined by enzyme-linked immunosorbent assay technique. sICAM-1 and sP-selectin values were significantly higher in patients with coronary artery disease than in control subjects [146(38) vs. 132(48) p < 0.04 and 275(107) vs. 241(104) ng/ml p < 0.04 respectively]. Multiple logistic regression analysis showed sICAM-1 an independent discriminating risk factor for coronary artery disease (p < 0.03). Prediction models that incorporated sICAM-1 in addition to other established coronary risk factors were significantly better at predicting risk than the models based on the other risk factors alone. Multiple regression analysis indicated that sP-selectin levels were greater in patients with single-vessel disease than in the respective normal (p < 0.01).
CONCLUSIONS: Our findings suggest that sICAM-1 has an association with s1 coronary artery disease as such; the evaluation of this marker may improve the coronary risk assessment in Iranian patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15495786     DOI: 10.1081/imm-120037275

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  4 in total

1.  Tumor necrosis factor receptor 2 M196R polymorphism in rheumatoid arthritis and osteoarthritis: relationship with sTNFR2 levels and clinical features.

Authors:  Edith Oregón-Romero; Mónica Vázquez-Del Mercado; Rosa Elena Navarro-Hernández; Norma Torres-Carrillo; Gloria Martínez-Bonilla; Iris Estrada-García; Héctor Rangel-Villalobos; José Francisco Muñoz-Valle
Journal:  Rheumatol Int       Date:  2006-07-27       Impact factor: 2.631

Review 2.  ICAM-1 gene rs5498 polymorphism decreases the risk of coronary artery disease.

Authors:  Ailing Liu; Ailing Wan; Aifang Feng; Ruping Rui; Bingzhi Zhou
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

3.  Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients.

Authors:  J Víšek; M Bláha; V Bláha; M Lášticová; M Lánska; C Andrýs; J Duintjer Tebbens; Ivone Cristina Igreja E Sá; K Tripská; M Vicen; I Najmanová; P Nachtigal
Journal:  Orphanet J Rare Dis       Date:  2021-02-27       Impact factor: 4.123

4.  Expression, production, and renaturation of a functional single-chain variable antibody fragment (scFv) against human ICAM-1.

Authors:  H Sun; G M Wu; Y Y Chen; Y Tian; Y H Yue; G L Zhang
Journal:  Braz J Med Biol Res       Date:  2014-06-04       Impact factor: 2.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.